A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...